Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000910

Drug Information
NameRescinnamine
SynonymsCCRIS 4711; Normorescina; NSC15628; ACon1_002115; Cinnaloid; O-(3,4,5-Trimethoxy-trans-cinnamoyl) methyl reserpate; Apolon; Apoterin S; Rescinpal; Raurescin; Reserpinin; Tsuruselpi S; Cinnasil; Rescin; Trimethoxy cinnamoyl reserpate de methyl; Rescinnamine [BAN:INN:JAN]; Cinatabs; Rescinamina [INN-Spanish]; BRD-K52930707-001-04-8; Recinnamine; Resealoid; Trimethoxycinnamoyl methyl reserpate; Rescinnamina; 3,4,5-Trimethoxycinnamic acid, methyl reserpate; C06540; NSC 15628; 3,4,5-Trimethylcinnamic acid, ester with methyl reserpate; BRN 0075328; Reserpinene; Methyl reserpate 3,4,5-trimethoxycinnamic acid ester; UNII-Q6W1F7DJ2D; Anapral; MEGxp0_001952; Resipal; Reserpinine (C35 alkaloid); Rescidan; Prestwick_558; Cinamine; Reserpic acid methyl ester 3,4,5-trimethoxycinnamate; Reserpinine; Tenamine; Reskinnamin; Rescisan; Cartric; Rescinnamina [DCIT]; Raurescine; Rescinnamin; BPBio1_000392; BRD-K52930707-001-02-2; Paresinan; Rozex; Rescamin; Prestwick3_000568; 3,4,5-Trimethylcinnamoyl methyl reserpate; Raupyrol; 4-25-00-01323 (Beilstein Handbook Reference); Tuareg; C35H42N2O9; D00198; Rescinnaminum; MLS002153878; Rescinnamine (JAN/INN); Methyl 18-O-(3,4,5-trimethoxycinnamoyl)reserpate; LS-1060; Prestwick2_000568; SMR001233232; Scinnamina; Resepinine (C35 alkaloid); 3,4,5-Trimethoxycinnamoyl methyl reserpate; HMS1569B18; Rescitens; rescinnamine; Methyl trimethoxycinnamoylreserpate; Moderil; Rescinnamine (VAN); Anaprel; Reserpinine (VAN); CHEMBL1668; MolPort-001-742-634; CID5280954; Rescaloid; EINECS 246-471-8; 84-34-4; BSPBio_000356; CHEBI:28572; Trimethoxy cinnamoyl reserpate de methyl [French]; Tsuruselpi S (TN); HSDB 2176; Rescinnaminum [INN-Latin]; Recitensina; NP-011016; AI3-52763; 24815-24-5; DB01180; Rescinamina; Apoterin
Trade NameModeril; Cinnasil; Anaprel
IndicationHypertension
[ICD9: 401   ICD10: I10, I11, I12, I13, I15]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10
-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(2
0)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,
36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1
InChIKeySZLZWPPUNLXJEA-QEGASFHISA-N
Canonical SMILESCOC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C
(=C6)OC)OC)OC    
Isomeric SMILESCO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC
(=C5)OC)OC(=O)/C=C/C6=CC(=C(C(=C6)OC)OC)OC
Therapeutic ClassAntihypertensive Agents
CAS NumberCAS 24815-24-5
FormulaC35H42N2O9
PubChem Compound IDCID 5280954.
PubChem Substance IDSID 8770.
ChEBI28572;
SuperDrug ATC IDC02AA01
SuperDrug CAS ID024815245;
TargetAngiotensin-converting enzymeInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 010686 To Reference
Ref 2Colorimetric determination of indolic drugs. Pak J Pharm Sci. 2005 Apr;18(2):48-51. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543